A recent article presents a molecular analysis of High-Grade Gliomas in teenagers and young adults (TYAs).
To maximise the benefit of this advancing knowledge we must address the basics.
Here, we highlight the challenge of lengthy diagnostic intervals for TYAs, arguing that these must reduce to reap the benefits of molecular insights.
